España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health, s.l. - herpesvirus del pavo (mdv tipo 3) vivo atenuado, cepa f126 - suspensiÓn inyectable - excipientes: sacarosa, rojo fenol, suero fetal de ternero, dimetilsulfoxido, caseina pancreatica (producto digestiÓn), dihidrogenofosfato de potasio, agua para preparaciones inyectables - virus del herpes aviar (enfermedad de marek) - pollos

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis spain s.l. - herpesvirus equino inactivado tipo 1, cepa 438/77 - suspensiÓn inyectable - herpesvirus equino inactivado tipo 1, cepa 438/77 1potencia relativa - virus de la rinoneumonitis equina - caballos

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health s.l. - herpesvirus del pavo (mdv tipo 3) vivo atenuado, cepa f126 - concentrado y disolvente para suspensiÓn inyectable - herpesvirus del pavo (mdv tipo 3) vivo atenuado, cepa f126 min.3,0 log 10unidades formadoras de placa (ufp) - virus del herpes aviar (enfermedad de marek) - pollos de engorde; huevos embrionados de gallina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis spain s.l. - herpesvirus del pavo (mdv tipo 3) vivo atenuado, cepa f126 - suspensiÓn y disolvente para suspensiÓn inyectable - herpesvirus del pavo (mdv tipo 3) vivo atenuado, cepa f126 10^3,0unidades formadoras de placa (ufp) - virus del herpes aviar (enfermedad de marek) - pollos de engorde; gallina-pollitas futuras ponedoras; gallina-pollitas futuras reproductoras

Unión Europea - español - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - inmunológicos para aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

vetia animal health, s.a.u - herpesvirus bovino tipo 1 (bhv-1), vivo atenuado, cepa bio-27 - liofilizado y disolvente para suspensiÓn inyectable - herpesvirus bovino tipo 1 (bhv-1), vivo atenuado, cepa bio-27 501187.23 dosis infectiva 50% en cultivo celular - virus de la rinotraqueitis bovina (ibr) - bovino

Unión Europea - español - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - inmunológicos para aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.